Literature DB >> 8419322

Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells.

K Itoh1, N Takiyama, R Kase, K Kondoh, A Sano, A Oshima, H Sakuraba, Y Suzuki.   

Abstract

Chinese hamster ovary cells were transfected with a recombinant DNA containing the entire coding sequence of human lysosomal protective protein cDNA under the control of mouse metallothionein I promoter. Neomycin and methotrexate-resistant stably transformed cell lines expressing this protein were isolated. Immunoprecipitation of the product with antiserum against human placental protective protein-beta-galactosidase complex revealed a 52-kDa protective protein precursor, which was then processed to mature form, a heterodimer of 32- and 20-kDa polypeptides. The precursor secreted in the culture medium was taken up by the mannose 6-phosphate receptor system and restored acid carboxypeptidase, beta-galactosidase, and neuraminidase activities in galactosialidosis fibroblasts. The expressed protein showed a granular pattern in intracellular distribution, was fractionated at the density of lysosomes, and had serine esterase activities; acid carboxypeptidase at pH 5.6, esterase at pH 7.0, and carboxyl-terminal deamidase at pH 7.0. They were inhibited simultaneously by phenylmethylsulfonyl fluoride, N-benzyloxycarbonyl-L-phenylalanine chloromethyl ketone, or iodoacetamide. The acid carboxypeptidase activity of the purified monomeric mature protective protein was labile in vitro under the acidic condition. Saposins (sphingolipid activator proteins) stabilized the activity at micromolar level concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.

Authors:  Y Naganawa; K Itoh; M Shimmoto; S Kamei; K Takiguchi; H Doi; H Sakuraba
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

2.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.

Authors:  X Jiang; O L Francone; C Bruce; R Milne; J Mar; A Walsh; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

3.  Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein.

Authors:  Yuto Horii; Toshiki Iniwa; Masayoshi Onitsuka; Jun Tsukimoto; Yuki Tanaka; Hironobu Ike; Yuri Fukushi; Haruna Ando; Yoshie Takeuchi; So-Ichiro Nishioka; Daisuke Tsuji; Mariko Ikuo; Naoshi Yamazaki; Yoshiharu Takiguchi; Naozumi Ishimaru; Kohji Itoh
Journal:  Mol Ther Methods Clin Dev       Date:  2022-04-15       Impact factor: 5.849

4.  Regulation of Escherichia coli starvation sigma factor (sigma s) by ClpXP protease.

Authors:  T Schweder; K H Lee; O Lomovskaya; A Matin
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

5.  Proteolytic activation of human cathepsin A.

Authors:  Nilima Kolli; Scott C Garman
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

6.  Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.

Authors:  R A Anderson; R S Byrum; P M Coates; G N Sando
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.

Authors:  Y Okamura-Oho; S Zhang; W Hilson; A Hinek; J W Callahan
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.